Definitive Healthcare Valuation
| DH Stock | USD 1.40 0.01 0.71% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Definitive Healthcare shows a prevailing Real Value of $1.92 per share. The current price of the firm is $1.4. Our model computes the value of Definitive Healthcare from reviewing the firm fundamentals such as Shares Outstanding of 103.3 M, profit margin of (0.58) %, and Current Valuation of 340.36 M as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Definitive Healthcare's valuation include:
Price Book 1.1416 | Enterprise Value | Enterprise Value Ebitda 46.6922 | Price Sales 0.6033 | Forward PE 12.3305 |
Undervalued
Today
Please note that Definitive Healthcare's price fluctuation is very risky at this time. Calculation of the real value of Definitive Healthcare is based on 3 months time horizon. Increasing Definitive Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Definitive Healthcare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Definitive Stock. However, Definitive Healthcare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.4 | Real 1.92 | Target 3.53 | Hype 1.39 | Naive 1.34 |
The intrinsic value of Definitive Healthcare's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Definitive Healthcare's stock price.
Estimating the potential upside or downside of Definitive Healthcare Corp helps investors to forecast how Definitive stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Definitive Healthcare more accurately as focusing exclusively on Definitive Healthcare's fundamentals will not take into account other important factors: When choosing an evaluation method for Definitive Healthcare, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Definitive Healthcare Cash |
|
Definitive Healthcare Total Value Analysis
Definitive Healthcare Corp is currently forecasted to have takeover value of 340.36 M with market capitalization of 145.72 M, debt of 253.11 M, and cash on hands of 347.87 M. Please note that takeover value may be misleading and is a subject to accounting mistakes. We encourage investors to methodically examine all of the Definitive Healthcare fundamentals before making investment evaluation based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
340.36 M | 145.72 M | 253.11 M | 347.87 M |
Definitive Healthcare Investor Information
About 90.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.14. Some equities with similar Price to Book (P/B) outperform the market in the long run. Definitive Healthcare has Price/Earnings To Growth (PEG) ratio of 1.03. The entity recorded a loss per share of 1.72. The firm had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Definitive Healthcare's historical financial statements, Definitive Healthcare Corp is not in a good financial situation at this time. It has a very high odds of going through financial crisis in March.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 37.6 M | 66.9 M |
|
|
Definitive Healthcare Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Definitive Healthcare has an asset utilization ratio of 23.15 percent. This signifies that the Company is making $0.23 for each dollar of assets. An increasing asset utilization means that Definitive Healthcare Corp is more efficient with each dollar of assets it utilizes for everyday operations.Definitive Healthcare Profitability Analysis
Based on the measurements of profitability obtained from Definitive Healthcare's financial statements, Definitive Healthcare Corp may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in March. Profitability indicators assess Definitive Healthcare's ability to earn profits and add value for shareholders.Net Loss | First Reported 2020-03-31 | Previous Quarter -7.6 M | Current Value -14.8 M | Quarterly Volatility 60 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.59 | 0.7588 |
|
|
For Definitive Healthcare profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Definitive Healthcare to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Definitive Healthcare utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Definitive Healthcare's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Definitive Healthcare over time as well as its relative position and ranking within its peers.
Definitive Healthcare Earnings per Share Projection vs Actual
By analyzing Definitive Healthcare's earnings estimates, investors can diagnose different trends across Definitive Healthcare's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Definitive Healthcare Corp is based on EPS before non-recurring items and includes expenses related to employee stock options.Definitive Healthcare Ownership Allocation
Definitive Healthcare holds a total of 103.3 Million outstanding shares. The majority of Definitive Healthcare Corp outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Definitive Healthcare to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Definitive Healthcare. Please pay attention to any change in the institutional holdings of Definitive Healthcare Corp as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Definitive Healthcare Profitability Analysis
The company generated the yearly revenue of 252.2 M. Annual Net Loss to common stockholders was (591.45 M) with gross profit of 203.57 M.About Definitive Healthcare Valuation
An absolute valuation paradigm, as applied to Definitive Stock, attempts to find the value of Definitive Healthcare based on its fundamental and basic technical indicators. By analyzing Definitive Healthcare's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Definitive Healthcare's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Definitive Healthcare. We calculate exposure to Definitive Healthcare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Definitive Healthcare's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 227.1 M | 153.5 M | |
| Pretax Profit Margin | (0.87) | (0.91) | |
| Operating Profit Margin | (0.93) | (0.98) | |
| Net Loss | (0.58) | (0.60) | |
| Gross Profit Margin | 0.76 | 0.59 |
Definitive Healthcare Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 116.6 M | |
| Forward Price Earnings | 12.3305 |
Definitive Healthcare Current Valuation Indicators
Valuation refers to the process of determining the present value of Definitive Healthcare Corp and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Definitive we look at many different elements of the entity such as Definitive's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Definitive Healthcare, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Definitive Healthcare's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Definitive Healthcare's worth.Complementary Tools for Definitive Stock analysis
When running Definitive Healthcare's price analysis, check to measure Definitive Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Definitive Healthcare is operating at the current time. Most of Definitive Healthcare's value examination focuses on studying past and present price action to predict the probability of Definitive Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Definitive Healthcare's price. Additionally, you may evaluate how the addition of Definitive Healthcare to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |